These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 3688677)

  • 1. Benefit-risk considerations in preventive treatment for tuberculosis in elderly persons.
    Stead WW; To T; Harrison RW; Abraham JH
    Ann Intern Med; 1987 Dec; 107(6):843-5. PubMed ID: 3688677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preventive treatment for tuberculosis in elderly persons.
    Ann Intern Med; 1988 Jun; 108(6):908-9. PubMed ID: 3369787
    [No Abstract]   [Full Text] [Related]  

  • 3. Underutilization of isoniazid chemoprophylaxis in tuberculosis contacts 50 years of age and older. A prospective analysis.
    Sorresso DJ; Mehta JB; Harvill LM; Bentley S
    Chest; 1995 Sep; 108(3):706-11. PubMed ID: 7656620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The age threshold for isoniazid chemoprophylaxis. A decision analysis for low-risk tuberculin reactors.
    Rose DN; Schechter CB; Silver AL
    JAMA; 1986 Nov; 256(19):2709-13. PubMed ID: 3773178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The competing risks of tuberculosis and hepatitis for adult tuberculin reactors.
    Comstock GW; Edwards PQ
    Am Rev Respir Dis; 1975 May; 111(5):573-7. PubMed ID: 1130750
    [No Abstract]   [Full Text] [Related]  

  • 6. Should young adults with a positive tuberculin test take isoniazid?
    Taylor WC; Aronson MD; Delbanco TL
    Ann Intern Med; 1981 Jun; 94(6):808-13. PubMed ID: 7235424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitored isoniazid prophylaxis for low-risk tuberculin reactors older than 35 years of age: a risk-benefit and cost-effectiveness analysis.
    Salpeter SR; Sanders GD; Salpeter EE; Owens DK
    Ann Intern Med; 1997 Dec; 127(12):1051-61. PubMed ID: 9412307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tuberculosis prevention: cost-effectiveness analysis of isoniazid chemoprophylaxis.
    Rose DN; Schechter CB; Fahs MC; Silver AL
    Am J Prev Med; 1988; 4(2):102-9. PubMed ID: 3134928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The significance of the tuberculin skin test in elderly persons.
    Stead WW; To T
    Ann Intern Med; 1987 Dec; 107(6):837-42. PubMed ID: 3688676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tuberculosis among elderly persons: an outbreak in a nursing home.
    Stead WW
    Ann Intern Med; 1981 May; 94(5):606-10. PubMed ID: 7235393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isoniazid as preventive therapy in HIV-infected intravenous drug abusers. A decision analysis.
    Jordan TJ; Lewit EM; Montgomery RL; Reichman LB
    JAMA; 1991 Jun; 265(22):2987-91. PubMed ID: 2033771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isoniazid preventive therapy in areas of high isoniazid resistance.
    Sterling TR; Brehm WT; Frieden TR
    Arch Intern Med; 1995 Aug 7-21; 155(15):1622-8. PubMed ID: 7618985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predisposing factors in hepatitis induced by isoniazid-rifampin treatment of tuberculosis.
    Grönhagen-Riska C; Hellstrom PE; Fröseth B
    Am Rev Respir Dis; 1978 Sep; 118(3):461-6. PubMed ID: 707874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preventive chemotherapy for HIV-associated tuberculosis in Uganda: an operational assessment at a voluntary counselling and testing centre.
    Aisu T; Raviglione MC; van Praag E; Eriki P; Narain JP; Barugahare L; Tembo G; McFarland D; Engwau FA
    AIDS; 1995 Mar; 9(3):267-73. PubMed ID: 7755915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acetylation rates and monthly liver function tests during one year of isoniazid preventive therapy.
    Mitchell JR; Long MW; Thorgeirsson UP; Jollow DJ
    Chest; 1975 Aug; 68(2):181-90. PubMed ID: 1080096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A tuberculin screening and isoniazid preventive therapy program in an inner-city population.
    Bock NN; Metzger BS; Tapia JR; Blumberg HM
    Am J Respir Crit Care Med; 1999 Jan; 159(1):295-300. PubMed ID: 9872853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Containment of tuberculosis. Preventive therapy with isoniazid, and contact investigation.
    Iseman MD
    Chest; 1979 Dec; 76(6 Suppl):801-4. PubMed ID: 389579
    [No Abstract]   [Full Text] [Related]  

  • 18. Isoniazid-related fatal hepatitis.
    Millard PS; Wilcosky TC; Reade-Christopher SJ; Weber DJ
    West J Med; 1996 Jun; 164(6):486-91. PubMed ID: 8764622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemic tuberculosis in a nursing home: a retrospective cohort study.
    Narain JP; Lofgren JP; Warren E; Stead WW
    J Am Geriatr Soc; 1985 Apr; 33(4):258-63. PubMed ID: 3989187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preventive treatment of tuberculosis.
    Bailey WC; Byrd RB; Glassroth JL; Hopewell PC; Reichman LB
    Chest; 1985 Feb; 87(2 Suppl):128S-132S. PubMed ID: 3967548
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.